|

Dapagliflozin 10mg Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Yale University1

Indications

  • Hyperinsulinism1
  • HER2-negative Breast Cancer1
  • Breast Cancer1
  • Cancer1

New Haven, Connecticut1 trial

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant with Neoadjuvant Therapy

Yale Cancer Center Smilow Cancer Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.